MedPath
NMPA Approval

Doxofylline for Injection

国药准字H20052247

July 1, 2020

国药准字H20052247

Drug Information

注射用多索茶碱

喜思诺

喜思诺

注射剂

0.1g(按多索茶碱计)

化学药品

July 1, 2020

Company Information

Applicant Company

Manufacturing Company

中山市国家健康科技产业基地

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用多索茶碱 - NMPA 批准文号 | MedPath